The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations
Yıl: 2022 Cilt: 47 Sayı: 5 Sayfa Aralığı: 640 - 646 Metin Dili: İngilizce DOI: 10.1515/tjb-2021-0231 İndeks Tarihi: 08-05-2023
The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations
Öz: Objectives: The main etiological factor in intrauterine growth restriction (IUGR) is the impairment of the fetoplacental unit. Due to the placental endothelial disintegrity and vascular permeability disruptions, endocan has been an interesting molecule to search for associations with IUGR. The aim of this study was to investigate the umbilical cord blood endocan concentrations in IUGR pregnancies. Methods: This cross-sectional case-control study was conducted on 50 IUGR-complicated (patients) and 50 control pregnancies. The demographics and clinical findings were recruited from records. The umbilical cord blood was studied for endocan concentrations. Results: The patient group compared to controls had significantly more previous IUGR history, lower maternal weight gain, an earlier gestational week at delivery, and more cesarean sections (p<0.001). The umbilical cord endocan concentrations were significantly higher in patients than in controls (p<0.001). Oligohydramnios (n=38) was significantly higher in the patients and had a significant relationship with high endocan concentrations (p<0.001). Moderate and mild positive correlations were found among endocan concentration and biparietal diameter/ head circumference and femur length values, respectively, while a moderate negative correlation was observed in abdominal circumference values (p<0.001). Conclusions: A significant increase in the umbilical cord blood endocan concentrations was found in IUGR pregnancies.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Nardozza LM, Caetano AC, Zamarian AC, Mazzola JB, Silva CP, Marcal VM, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet 2017;295:1061–77.
- 2. Gordijn SJ, Beune IM, Ganzevoort W. Building consensus and standards in fetal growth restriction studies. Best Pract Res Clin Obstet Gynaecol 2018;49:117–26.
- 3. Krishna U, Bhalerao S. Placental insufficiency and fetal growth restriction. J Obstet Gynaecol India 2011;61:505–11.
- 4. Szentpéteri I, Rab A, Kornya L, Kovács P, Joó JG. Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction. J Matern Fetal Neonat Med 2013;26:984–9.
- 5. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A. Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis 2015;243:339–43.
- 6. Kali A, Shetty KS. Endocan: a novel circulating proteoglycan. Indian J Pharmacol 2014;46:579.
- 7. Lee W, Ku S-K, Kim S-W, Bae J-S. Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol 2014; 229:620–30.
- 8. Chew BS, Ghazali R, Othman H, Ismail NA, Othman AS, Laim NM, et al. Endocan expression in placenta of women with hypertension. J Obstet Gynaecol Res 2019;45:345–51.
- 9. Zhao T, Kecheng Y, Zhao X, Hu X, Zhu J, Wang Y, et al. The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease. Medicine (Baltim) 2018;97:e13407.
- 10. Ovayolu A, Ovayolu G, Karaman E, Yuce T, Turgut A, Bostancleri N. Maternal serum endocan concentrations are elevated in patients with preterm premature rupture of membranes. J Perinat Med 2019;47:510–5.
- 11. Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonat Med 2015;28:1621–32.
- 12. Cakmak M, Yilmaz H, Baglar E, Darcin T, Inan O, Aktas A, et al. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Clin Exp Hypertens 2016;38:137–42.
- 13. Tanriverdi T, Kemerdere R, Inal B, Yuksel O, Emre H, Ahmedov M, et al. Serum endocan levels before and after surgery on low-grade gliomas. Surg Neurol Int 2017;8:32.
- 14. Lan X, Liu Z. Circulating endocan and preeclampsia: a metaanalysis. Biosci Rep 2020;40:BSR20193219.
- 15. YıldırımE, Turkler C, Demir E, Tuten A, Akcay A. Umbilical arterial endocan levels can predict early neonatal pneumonia: a prospective case-control study. Early Hum Dev 2020;142: 104952.
- 16. Güralp O, Acikgöz S, Tüten N, Ekmekci H, Schild-Suhren M, Malik E, et al. Evaluation of serum endocan levels in endometriosis: a case-control study. Clin Ter 2020;171: e517–22.
- 17. Lopes AC dos S, Martins SR, Dusse LM, Pinheiro M de B, Alpoim PN. Are endocan plasma levels altered in preeclampsia? Rev Bras Ginecol Obstet/RBGO Gynecol Obstet 2021;43:232–4.
- 18. Schuitemaker JH, Cremers TI, Van Pampus MG, Scherjon SA, Faas MM. Changes in endothelial cell-specific molecule 1 plasma levels during preeclamptic pregnancies compared to healthy pregnancies. Pregnancy Hypertens 2018;12:58–64.
- 19. Ovayolu A, Ovayolu G, Yuce T, Ozek MA, Dogan I, Bostancieri N. Amniotic fluid concentrations of soluble endoglin and endothelial cell-specific molecule-1 in pregnancies complicated with neural tube defects. J Perinat Med 2020;48: 132–8.
- 20. Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE, Polide- Figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine 2015;74:152–6.
- 21. Chang X, Bian Y, Wu Y, Huang Y, Wang K, Duan T. Endocan of the maternal placenta tissue is increased in pre-eclampsia. Int J Clin Exp Pathol 2015;8:14733–40.
- 22. Kucukbas GN, Kara O, Yüce D, Uygur D. Maternal plasma endocan levels in intrauterine growth restriction. J Matern Fetal Neonat Med 2020;14:1–6.
- 23. Szpera-Gozdziewicz A, Kosicka K, Gozdziewicz T, Krzyscin M, Wirstlein P, Siemiatkowska A, et al. Maternal serum endocan concentration in pregnancies complicated by intrauterine growth restriction. Reprod Sci 2019;26:370–6.
- 24. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. Practice Bulletin-Clinical Guidance 2020-ACOG No: 12. Available from: https://www.acog. org/clinical/clinical-guidance/practice-advisory/articles/2020/ 09/updated-guidance-regarding-fetal-growth-restriction.
- 25. Andıç E, Karaman E, Kolusarı A, Çokluk E. Association of cord blood ischemia-modified albumin level with abnormal foetal Doppler parameters in intrauterine growth-restricted foetuses. J Matern Fetal Neonat Med 2021;34:1–6.
- 26. Seferovic MD, Gupta MB. Increased umbilical cord PAI-1 levels in placental insufficiency are associated with fetal hypoxia and angiogenesis. Dis Markers 2016;2016:1–13.
- 27. Lindqvist PG, Balogh I, Dahlbäck B. Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction. Acta Obstet Gynecol Scand 2010;89:22–6.
- 28. Szpera-Goździewicz A, Kosicka K, Goździewicz T, Krzyścin M, Wirstlein P, Siemiątkowska A, et al. Serum endocan concentration and its correlation with severity of hypertensive disorders in pregnancy. J Matern Fetal Neonat Med 2020;33:2313–9.
- 29. Owa JA, Adebami OJ. Looking for the best indicator fetal malnutrition: an overview. Internet J Nutr Wellness 2006;3: 1–5.
| APA | Özgökçe Ç, uckan K, Meral A (2022). The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. , 640 - 646. 10.1515/tjb-2021-0231 |
| Chicago | Özgökçe Çağdaş,uckan Kazım,Meral Ayfer The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. (2022): 640 - 646. 10.1515/tjb-2021-0231 |
| MLA | Özgökçe Çağdaş,uckan Kazım,Meral Ayfer The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. , 2022, ss.640 - 646. 10.1515/tjb-2021-0231 |
| AMA | Özgökçe Ç,uckan K,Meral A The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. . 2022; 640 - 646. 10.1515/tjb-2021-0231 |
| Vancouver | Özgökçe Ç,uckan K,Meral A The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. . 2022; 640 - 646. 10.1515/tjb-2021-0231 |
| IEEE | Özgökçe Ç,uckan K,Meral A "The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations." , ss.640 - 646, 2022. 10.1515/tjb-2021-0231 |
| ISNAD | Özgökçe, Çağdaş vd. "The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations". (2022), 640-646. https://doi.org/10.1515/tjb-2021-0231 |
| APA | Özgökçe Ç, uckan K, Meral A (2022). The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. Türk Biyokimya Dergisi, 47(5), 640 - 646. 10.1515/tjb-2021-0231 |
| Chicago | Özgökçe Çağdaş,uckan Kazım,Meral Ayfer The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. Türk Biyokimya Dergisi 47, no.5 (2022): 640 - 646. 10.1515/tjb-2021-0231 |
| MLA | Özgökçe Çağdaş,uckan Kazım,Meral Ayfer The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. Türk Biyokimya Dergisi, vol.47, no.5, 2022, ss.640 - 646. 10.1515/tjb-2021-0231 |
| AMA | Özgökçe Ç,uckan K,Meral A The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. Türk Biyokimya Dergisi. 2022; 47(5): 640 - 646. 10.1515/tjb-2021-0231 |
| Vancouver | Özgökçe Ç,uckan K,Meral A The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations. Türk Biyokimya Dergisi. 2022; 47(5): 640 - 646. 10.1515/tjb-2021-0231 |
| IEEE | Özgökçe Ç,uckan K,Meral A "The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations." Türk Biyokimya Dergisi, 47, ss.640 - 646, 2022. 10.1515/tjb-2021-0231 |
| ISNAD | Özgökçe, Çağdaş vd. "The relationship between pregnancies complicated with fetal growth restriction and umbilical cord blood endocan concentrations". Türk Biyokimya Dergisi 47/5 (2022), 640-646. https://doi.org/10.1515/tjb-2021-0231 |
